Literature DB >> 19740901

Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement.

Jasemine Saech, Kasia Owczarczyk, Kasia Owczarzyk, Sylvia Rösgen, Hela Petereit, Michael Hallek, Andrea Rubbert-Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19740901     DOI： 10.1136/ard.2009.109850

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  12 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  The diagnostic conundrum of primary angiitis of the central nervous system: a case report.

Authors:  Dipender Gill; Stephan Hinze; Jacqueline Palace
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

Review 3.  Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis.

Authors:  Jeremy M Clain; Rodrigo Cartin-Ceba; Fernando C Fervenza; Ulrich Specks
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

4.  Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Authors:  Alana B Levine; George Kalliolias; Mark Heaney; Yoshimi Endo; Adam Gersten; Jonathan W Weinsaft; Robert F Spiera; Anne Bass; Doruk Erkan
Journal:  HSS J       Date:  2012-06-23

5.  Successful use of Rituximab in a patient with recalcitrant multisystemic eosinophilic granulomatosis with polyangiitis.

Authors:  Catherine E Najem; Rajwardhan Yadav; Elise Carlson
Journal:  BMJ Case Rep       Date:  2015-05-15

6.  Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis.

Authors:  Naomi Tsurikisawa; Hiroshi Saito; Chiyako Oshikata; Takahiro Tsuburai; Kazuo Akiyama
Journal:  J Clin Immunol       Date:  2013-04-27       Impact factor: 8.317

7.  Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.

Authors:  Rodrigo Cartin-Ceba; Karina A Keogh; Ulrich Specks; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2011-02-16       Impact factor: 5.992

Review 8.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

9.  Toxicities of immunosuppressive treatment of autoimmune neurologic diseases.

Authors:  Enrico C Lallana; Camilo E Fadul
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

10.  Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Authors:  Jens Thiel; Fabian Hässler; Ulrich Salzer; Reinhard E Voll; Nils Venhoff
Journal:  Arthritis Res Ther       Date:  2013-09-24       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.